Log in to your Inderes Free account to see all free content on this page.
BICO Group
36.4
SEK
+5.14 %
BICO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
5 following
+5.14%
-9.45%
-21.21%
-17.35%
-36.1%
-30.93%
-88.65%
-50.98%
+167.16%
bico.com/investors
BICO Group is active in medical technology. The company specializes in bio convergence and provides technology, products, and services for biology. With a focus on the application areas bioprinting, multi-omics, cell line development, and diagnostics, the company develops and markets technology that enables researchers to grow cells in 3D environments, conduct drug screening, and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries.
Revenue
2.25B
EBIT %
-64.44 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BICO
Daily low / high price
35.2 / 37.2
SEK
Market cap
2.57B SEK
Turnover
6.26M SEK
Volume
174K
Latest videos
Financial calendar
Interim report
26.11.2024
Annual report
19.02.2025
Interim report
29.04.2025
General meeting
08.05.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Erik Gatenholm | 13.6 % | 20.5 % |
Sartorius AG | 10.1 % | 8.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
BICO has entered into an agreement to divest Nanoscribe
BICO, Audiocast with teleconference, Q3'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio